Latest Articles

Publication Date
All News Scientific
Proposal for Managing Cancer-Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment.

Insomnia is common in patients with cancer. It has a multifactorial etiology that may include the disease process, adverse effects of anticancer therapies, and/or an association with other comorbidities. The …

Published: Nov. 27, 2024, midnight
Read Full Article
cancer insomnia psycho‐oncology review sleep disturbance
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - Oncology News Central

3 FDA Approvals Signal Year of Change for Endometrial Cancer Care Oncology News Central

Published: Nov. 13, 2024, 11:41 a.m.
Read Full Article
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - oncologynewscentral.com

3 FDA Approvals Signal Year of Change for Endometrial Cancer Care oncologynewscentral.com

Published: Nov. 13, 2024, 11:41 a.m.
Read Full Article
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times

Published: Oct. 23, 2024, 10:06 a.m.
Read Full Article
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More - Targeted Oncology

The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More Targeted Oncology

Published: June 23, 2024, 7 a.m.
Read Full Article
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer - Oncology News Central

FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer Oncology News Central

Published: June 17, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire

Published: April 24, 2024, 7 a.m.
Read Full Article
Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology - ASCO Daily News

Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology ASCO Daily News

Published: April 24, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting Investor Relations | Karyopharm Therapeutics

Published: April 24, 2024, 7 a.m.
Read Full Article
Molecular Classification May Predict Survival Outcomes in Endometrial Cancer - Oncology Learning Network

Molecular Classification May Predict Survival Outcomes in Endometrial Cancer Oncology Learning Network

Published: April 1, 2024, 7 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!